Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Announces Date of FDA Advisory Committee Review of Probuphine(R) for the Treatment of Opioid Dependence

February 27, 2013

Probuphine(R) Receives FDA Priority Review Designation for Adult Patients With Opioid Dependence

January 2, 2013

Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals

December 17, 2012

Titan Pharmaceuticals Announces Third Quarter 2012 Financial Results

November 12, 2012

Titan Pharmaceuticals Announces $4.25 Million Stock Purchase and Option Agreement

September 14, 2012

Titan Pharmaceuticals Announces Second Quarter 2012 Financial Results

August 10, 2012

Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2012 Financial Results

August 8, 2012

Titan Completes Preclinical Study of a Continuous, Dopamine Agonist Treatment for Parkinson's Disease

July 9, 2012

Titan Pharmaceuticals Announces First Quarter 2012 Financial Results

May 11, 2012

Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2012 Financial Results

May 9, 2012

  • « Previous
  • 1...
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next »
© 2023 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter